DataSheet1_Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine.docx by Liang Zheng (206933)

Decreased fitness correlates with altered cell cycle progression. by Scott A. Hoose (167376)

Production of semaphorin-7A in the NIH3T3 fibroblast cell line decreases expression of periostin and fibronectin. by Stephane Esnault (24104)

Decreased NR1 and NR2A protein expression in 21-day group. by Chenxia Han (4020017)

Temperature anomalies and mean annual precipitation. by Giovanna Battipaglia (711570)

<i>L. monocytogenes</i> causes LLO-mediated downregulation of CD117 but not FcεRI on BMMC and decreases chemotaxis. by Catherine E. Jobbings (382681)

Use of the 9-item Shared Decision Making Questionnaire (SDM-Q-9 and SDM-Q-Doc) in intervention studies—A systematic review by Hanna Doherr (3878455)

“…We extracted the data using a pilot tested sheet, and we assessed the methodological quality of included studies using the Quality Assessment Tools from the U.S. …”

Relative decreases in VP mean weights using -DDE against TP controls in nine laboratories (Lab) by William Owens (20777)

Relative decreases in VP mean weights using VIN against TP controls in eight laboratories (Lab) by William Owens (20777)

Western blotting indicates TSPO protein expression decreases on treatment of MDM with M1 stimuli LPS plus IFN-γ. by Nehal Narayan (4484434)

Study selection criteria. by Filip Stanicic (17808254)

“…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …”

PICOS criteria for the SLR. by Filip Stanicic (17808254)

“…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …”

PRISMA flow chart. by Filip Stanicic (17808254)

“…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …”

Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines by Elaine Langenfeld (402034)

“…Lung cancer cell lines express alk2, alk3, and alk6 and inhibition of a single BMP receptor was not sufficient to decrease signaling. …”

Mean firing rate of the <i>k</i>-populations for decreasing sub-threshold stimulus <i>s</i>. by Christian Schmeltzer (761655)

Impairment of autophagy decreases S129A aSyn-GFP clearance and increases toxicity. by Sandra Tenreiro (13787)

IODVA1 inhibits lamellipodia and circular dorsal ruffle (CDR) formation in MDA-MB-231 cells and decreases Rac activation. by Anjelika Gasilina (8566296)

The Use of Alendronate Is Associated with a Decreased Incidence of Type 2 Diabetes Mellitus—A Population-Based Cohort Study in Taiwan by Ding-Cheng Chan (549939)

Simultaneous downregulation of LIFR and OSMR decreases IL-6 and MCP-1 release and prevents STAT1 and STAT3 phosphorylation. by Danielle van Keulen (5807507)

Decoy Wnt receptor sLRP6E1E2 decreases proliferation in human lung cancer cells. by Jung-Sun Lee (164985)